Dergiler / Dicle Tıp Dergisi / 2021 / Cilt: 48 - Sayı: 3

Effects of electroporation on cytotoxicity of 4-aminopyrimidin-2- (1H)-one based ligand and its Cobalt (II) and Ruthenium (II) complexes in MCF-7 cancer cells

Elektroporasyonun MCF-7 kanser hücrelerinde 4-aminopirimidin-2- (1H)-on ana maddesinden sentezlenen ligand ile Kobalt (II) ve Rutenyum (II) komplekslerinin sitotoksisiteleri üzerindeki etkisi

Sayfa
498–506
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The results of the present study demonstrated that Co(II) and Ru(II) complexes may contribute as potential chemotherapeutic agents for the treatment of breast cancer and ECT can reduce the side effects of agents by providing treatment with a lower doses of compounds.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of this study was to investigate the underlying causes of obstetrical disseminated intravascular coagulation (DIC) Objective: Cancer is a complicated disease and ranks near the top among the causes of death across the world.
📊
Temel Bulgular & Veri:The purpose of the study is to examine the cytotoxicity of the cytosine-based ligand and its cobalt and ruthenium complexes in MCF-7 cancer cells and L-929 healthy cells, and to determine the effects of EP on the anticancer activities of these compounds.Methods: In the present study, firstly, the cytotoxic activities of the ligand and its cobalt (Co) and ruthenium (Ru) complexes were examined against MCF-7 cancer cells and L-929 healthy cells.
💡
Sonuç & Katkı:Conclusion: The results of the present study demonstrated that Co(II) and Ru(II) complexes may contribute as potential chemotherapeutic agents for the treatment of breast cancer and ECT can reduce the side effects of agents by providing treatment with a lower doses of compounds.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The aim of this study was to investigate the underlying causes of obstetrical disseminated intravascular coagulation (DIC) Objective: Cancer is a complicated disease and ranks near the top among the causes of death across the world. Electrochemotherapy (ECT) is a local treatment method in which chemotherapy and electroporation (EP) are used in combination to facilitate the entry of drugs into cells. The purpose of the study is to examine the cytotoxicity of the cytosine-based ligand and its cobalt and ruthenium complexes in MCF-7 cancer cells and L-929 healthy cells, and to determine the effects of EP on the anticancer activities of these compounds.Methods: In the present study, firstly, the cytotoxic activities of the ligand and its cobalt (Co) and ruthenium (Ru) complexes were examined against MCF-7 cancer cells and L-929 healthy cells. Then, the effects of EP on the anticancer activities of these compounds were examined in MCF-7 cancer cells. Cytotoxicity activities of the compounds were determined by MTT viability test. Results: Co(II) and Ru(II) compounds showed the best cytotoxicity against MCF-7 cancer cells, while they displayed low cytotoxicity against the L-929 healthy cells. EP increased the cytotoxicity of the compounds significantly (p<0.05). A statistically significant decrease was observed in the percentages of cell viability of ligand+EP, Co(II)+EP, and Ru(II)+EP treatment groups compared to those of the compounds-alone and control groups (p <0.05). Conclusion: The results of the present study demonstrated that Co(II) and Ru(II) complexes may contribute as potential chemotherapeutic agents for the treatment of breast cancer and ECT can reduce the side effects of agents by providing treatment with a lower doses of compounds.

Abstract

Giriş: Kanser komplike bir hastalıktır ve dünya çapında ölüm nedenleri arasında ilk sıralarda yer almaktadır. Elektrokemoterapi (ECT), ilaçların hücrelere girişini kolaylaştırmak için kemoterapi ve elektroporasyonun (EP) birlikte kullanıldığı lokal bir tedavi yöntemidir. Bu çalışmanın amacı, sitozin ana maddesinden sentezlenmiş ligand ile onun kobalt ve rutenyum komplekslerinin MCF-7 kanser hücreleri ve L-929 sağlıklı hücrelerdeki sitotoksisitelerini incelemek ve EP'nin bu bileşiklerin antikanser aktiviteleri üzerindeki etkilerini belirlemektir. Yöntemler: Bu çalışmada ilk olarak, ligand ile kobalt (Co) ve rutenyum (Ru) komplekslerinin sitotoksik aktiviteleri MCF7 kanser hücreleri ve L-929 sağlıklı hücrelere karşı incelendi. Daha sonra, EP'nin bu bileşiklerin antikanser aktiviteleri üzerindeki etkileri MCF-7 kanser hücrelerinde belirlendi. Bileşiklerin sitotoksisite aktiviteleri MTT canlılık testi ile değerlendirildi. Bulgular: Co(II) ve Ru(II) bileşikleri, MCF-7 kanser hücrelerine karşı iyi sitotoksisite gösterirken, L-929 sağlıklı hücrelere karşı düşük sitotoksisite sergilediler. EP, bileşiklerin sitotoksisitesini önemli ölçüde artırdı (p <0.05). Ligand + EP, Co(II) + EP ve Ru(II) + EP tedavi gruplarının hücre canlılığı yüzdelerinde, sadece bileşik uygulanan ve kontrol gruplarınınkine kıyasla istatistiksel olarak anlamlı bir düşüş gözlendi (p <0.05). Sonuç: Bu çalışmanın bulguları, Co(II) ve Ru(II) komplekslerinin meme kanserinin tedavisi için potansiyel kemoterapötik ajan olarak katkıda bulunabileceklerini ve ECT'nin daha düşük doz bileşiklerle tedaviyi sağlayarak ajanların yan etkilerini azaltabileceğini göstermiştir.

🔖

Bu Makaleye Atıf Yap

ALKIŞ, M. E. (2021). Effects of electroporation on cytotoxicity of 4-aminopyrimidin-2- (1H)-one based ligand and its Cobalt (II) and Ruthenium (II) complexes in MCF-7 cancer cells. Dicle Tıp Dergisi, Cilt: 48 - Sayı: 3, 498–506. https://ajindex.com/articles/348756

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394-424
  2. Levitsky DO, Dembitsky VM. Anti-breast cancer agents derived from plants. Nat Products Bioprospect. 2014; 5: 1–16
  3. Michel O, Kulbacka J, Saczko J, et al. Electroporation with cisplatin against metastatic pancreatic cancer: In Vitro Study on human primary cell culture. Biomed Res Int. 2018; 2018: 1–12
  4. Çı̇ftcı̇ F. The role of breast-conserving surgery in the treatment of early-stage breast cancer. Dicle Med J. 2020; 852–8
  5. Housman G, Byler S, Heerboth S, et al. Drug resistance in cancer: an overview. Cancers (Basel). 2014; 6: 1769–92
  6. Ramesh G, Daravath S, Ganji N, et al. Facile synthesis, structural characterization, DNA binding, incision evaluation, antioxidant and antimicrobial activity studies of Cobalt (II), Nickle (II) and Copper (II) complexes of 3-amino-5-(4-fluorophenyl) isoxazole derivatives. J Mol Struct. 2020; 1202: 127338
  7. Thamilarasan V, Sengottuvelan N, Sudha A, Srinivasan P, Chakkaravarthi G. Cobalt (III) complexes as potential anticancer agents: Physicochemical, structural, cytotoxic activity and DNA/protein interactions. J Photochem Photobiol B. 2016; 162: 558–69
  8. Motswainyana WM, Ajibade PA. Anticancer activities of mononuclear ruthenium(II) coordination complexes. Adv Chem. 2015; 2015: 1– 21
  9. Zhu J, Wang F, Liu X, Tan L. Stabilization of an intermolecular RNA triplex by two novel binders Lys- and Arg-rich Ru(II) polypyridyl metallopeptides. J Inorg Biochem. 2020; 210: 111171
  10. Thota S, Rodrigues DA, Crans DC, Barreiro EJ. Ru (II) Compounds: Next-Generation Anticancer Metallotherapeutics? J Med Chem. 2018; 61: 5805– 5821
  11. Clover AJP, Salwa SP, Bourke MG, et al. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol. 2020; 46: 847– 54
  12. Probst U, Fuhrmann I, Beyer L, Wiggermann P. Electrochemotherapy as a new modality in interventional oncology: A review. Technol Cancer Res Treat. 2018; 17: 153303381878532
  13. Alkış ME, Keleştemür Ü, Alan Y, Turan N, Buldurun K. Cobalt and ruthenium complexes with pyrimidine based schiff base: Synthesis, characterization, anticancer activities and electrochemotherapy efficiency. J Mol Struct. 2021; 1226: 129402
  14. Alkış ME, Buldurun K, Turan N, e